参考文献/References:
[1] Drela E, Stankowska K, Kulwas A,et al.Endothelial progenitor cells in diabetic foot syndrome[J].Adv Clin Exp Med,2012,21(2):249-254.
[/br][2]Behm B,Babilas P,Landthaler M,et al.Cytokines,chemokines and growth factors in wound healing[J]. J Eur Acad Dermatol Venereol,2012,26(7):812-820.
[/br][3]Maxson S, Lopez EA, Yoo D,et al. Concise review: role of mesenchymal stem cells in wound repair[J].Stem Cells Transl Med,2012, 1(2):142-149.
[/br][4] Dinh T, Tecilazich F, Kafanas A,et al. Mechanisms involved in the development and healing of diabetic foot ulceration[J].Diabetes,2012, 61(11):2937-2947.
[/br][5] Martins-Green M, Petreaca M, Wang L.Chemokines and their receptors are key players in the orchestra that regulates wound healing[J].Adv Wound Care(New Rochelle),2013,2(7):327-347.
[/br][6] Bitto A, Irrera N, Minutoli L,et al.Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice[J].Clin Sci(Lond),2013,125(12):575-585.
[/br][7] Pradhan L,Cai X,Wu S,et al.Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing[J].J Surg Res,2011,167(2):336-342.
[/br][8] Ota T.Chemokine systems link obesity to insulin resistance[J].Diabetes Metab J,2013,37(3):165-172.
[/br][9] Martínez-Hervás S, Vinué A, Núñez L, et al.Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis[J].Cardiovasc Res,2014,103(2):324-336.
[/br][10] Okamoto M, Fuchigami M, Suzuki T,et al.A novel C-C chemokine receptor 2 antagonist prevents progression of albuminuria and atherosclerosis in mouse models[J]. Biol Pharm Bull,2012,35(11):2069-2074.
[/br][11] Meng L, Park J, Cai Q,et al.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation[J].Am J Physiol Heart Circ Physiol,2010,298(3): H736-H745.
[/br][12] Kolluru GK, Bir SC, Kevil CG.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing[J].Int J Vasc Med,2012,2012:918267.
[/br][13] Teraa M, Sprengers RW, Westerweel PE, et al. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients[J].PLoS One,2013,8(1): e55592.
[/br][14] Bosisio D, Salvi V, Gagliostro V, et al.Angiogenic and antiangiogenic chemokines[J].Chem Immunol Allergy,2014,99:89-104.
[/br][15] Kiefer F, Siekmann AF.The role of chemokines and their receptors in angiogenesis[J].Cell Mol Life Sci,2011,68(17):2811-2830.
[/br][16] Nishimura Y,Ii M,Qin G,et al.CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice[J].J Invest Dermatol,2012,132(3 Pt 1):711-720.
[/br][17] Kroeze KL, Boink MA, Sampat-Sardjoepersad SC,et al.Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3[J]. J Invest Dermatol,2012,132(1):216-225.
[/br][18] Allen RJ Jr, Soares MA, Haberman ID,et al.Combination therapy accelerates diabetic wound closure[J].PLoS One, 2014, 9(3):e92667.
[/br][19] Badr G, Badr BM, Mahmoud MH,et al.Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1α, MIP-2, KC, CX3CL1 and TGF-β in wounded tissue[J]. BMC Immunol,2012,13:32.
[/br][20] Wood S, Jayaraman V, Huelsmann EJ, et al.Pro-inflammatory chemokine CCL2(MCP-1)promotes healing in diabetic wounds by restoring the macrophage response[J]. PLoS One,2014,9(3):e91574.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(05):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]